Trials / Not Yet Recruiting
Not Yet RecruitingNCT06477497
The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
Placenta accreta spectrum (PAS) disorders are pathological attachment of the placenta to myometrium, where trophoblastic cells invade the uterine placental interface. PAS can lead to severe postpartum hemorrhage or even maternal death. Prenatal diagnosis of PAS is essential for optimal obstetric management to improve the pregnancy outcomes. However, in some low resource regions in China, less than 20% PAS are detected before delivery. To explore the feasibility and universality of the bundled prevention and treatment strategy for placenta accreta spectrum disorders in different levels of medical institutions, and to investigate its effectiveness in improving the specialized disease management capabilities of medical institutions at all levels. We will conduct a regional, cluster-randomized trial to assess a multicomponent PAS management strategy to improve the prepartum detection rate of PAS.
Conditions
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-11-30
- Completion
- 2025-11-30
- First posted
- 2024-06-27
- Last updated
- 2024-06-27
Source: ClinicalTrials.gov record NCT06477497. Inclusion in this directory is not an endorsement.